Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2012
03/22/2012WO2012034519A1 Tannin extract of sanguisorba officinalis l. and preparation method and use thereof
03/22/2012WO2012034379A1 Method for preparing ph sensitive metal organic coordination polymer
03/22/2012WO2012034363A1 Compounds of hedgehog pathway inhibitors, pharmaceutical compositions containing the same and uses thereof
03/22/2012WO2012034232A1 Terpenoid analogues and uses thereof for treating neurological conditions
03/22/2012WO2012034204A1 Pharmaceutical association for treating and/or preventing myoma and/or endometriosis, use of resveratrol and progestogen, pharmaceutical composition for treating and/or preventing myoma and/or endometriosis, medicament for treating and/or preventing myoma and/or endometriosis, kit and method for treating and/or preventing myoma and/or endometriosis
03/22/2012WO2012034194A1 Method for mobilizing stem and/or progenitor cells
03/22/2012WO2012034189A1 Methods of using mirnas transcribed from the 14q32 region of human chromosome 14 as biomarkers for schizophrenia or symptoms thereof
03/22/2012WO2012021107A8 A liposomal formulation for ocular drug delivery
03/22/2012WO2012019204A3 Therapeutic agent for intranasal administration and method of making and using same
03/22/2012WO2012016314A9 Arachidonic acid-derived coxib analogue-substituted compounds for use in treating pain
03/22/2012WO2012016109A3 Compounds and methods for skin repair
03/22/2012WO2012015758A3 Methods of treating pain
03/22/2012WO2012013850A3 Compound for treating neurodegenerative diseases, cognitive deficiencies and/or dementia
03/22/2012WO2012009723A8 C-met modulator pharmaceutical compositions
03/22/2012WO2012009155A3 Process and assembly for producing alkylene oxides and glycol ethers
03/22/2012WO2012001308A9 Method for synthesizing ergoline alkaloids from indolic bicyclic compounds by double cyclization, resulting materials, and intermediate materials
03/22/2012WO2012001074A3 Pharmaceutical compositions comprising 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one lactate monohydrate
03/22/2012WO2012001064A3 Use of alpha-adrenergic receptor agonist for preventing or treating skin tumor
03/22/2012WO2011163356A3 Methods of treating conditions associated with overactive bladder
03/22/2012WO2011161631A3 Compounds for treatment of tumors bearing deregulated myc oncoproteins
03/22/2012WO2011153323A3 Compositions and methods directed to treating liver fibrosis
03/22/2012WO2011149814A3 Effervescent composition for forming a gelled composition, tablet for forming a gelled composition, and method of making a gelled composition
03/22/2012WO2011149250A3 Tricarbonyl technetium-99m or rhenium-188 label ring rgd derivative, a preparation method thereof, and a pharmaceutical composition containing the derivative as an active ingredient for use in the diagnosis or treatment of angiogenesis-related diseases
03/22/2012WO2011141929A3 Aqueous pharmaceutical compositions of fluticasone and olopatadine
03/22/2012WO2011140525A3 Methods and compositions related to a retinoid receptor-selective pathway
03/22/2012WO2011139846A3 Compositions and methods for reduced scarring and for treatment of fibrosis
03/22/2012WO2011136585A3 Composition for treating bone disease comprising a glyceollin as an active ingredient
03/22/2012WO2011133712A3 Anti-viral compounds
03/22/2012WO2011132114A3 Tuberculosis drug based on 4-thioureido-iminomethylpyridinium perchlorate: method of preparation and treatment
03/22/2012WO2011130557A3 Phosphonates with reduced toxicity for treatment of viral infections
03/22/2012WO2011120474A9 Method for inhibiting hiv replication in mammal and human cells
03/22/2012WO2011116286A3 Stable bortezomib formulations
03/22/2012WO2011104490A3 Use of essential oil of oregano or of rosewood for the treatment of cancerous keratoses
03/22/2012WO2011104489A3 Use of essential oil of oregano or of rosewood in the treatment of actinic keratoses
03/22/2012WO2011097149A3 Taxane-and taxoid-protein compositions
03/22/2012WO2011085158A3 Stabilized formulations containing anti-interleukin-6 receptor (il-6r) antibodies
03/22/2012WO2011014417A3 Use of equol for treating skin diseases
03/22/2012WO2006046250A3 Compositions and methods for diagnosing and treating insulin resistance
03/22/2012WO2004050019A9 Method and compositions for treating anxiety
03/22/2012US20120073001 Methods and compositions for treating or preventing pruritis
03/22/2012US20120071967 One-step phosphorylcholine-linked polymer coating and drug loading of stent
03/22/2012US20120071859 Inducible interleukin-12
03/22/2012US20120071704 Mitochondrial localization of muc1
03/22/2012US20120071657 Triazole compounds useful as protein kinase inhibitors
03/22/2012US20120071653 Human Adam-10 Inhibitors
03/22/2012US20120071563 Stabilizer
03/22/2012US20120071562 2alpha-Methyl-19-Nor-(20S)-1alpha-Hydroxy-Bishomopregnacalciferol and Its Uses
03/22/2012US20120071561 Methods And Compositions For Prevention And Treatment Of Inflammatory Disease, Autoimmune Disease And Transplant Rejection
03/22/2012US20120071560 Monoamine reuptake inhibitors
03/22/2012US20120071559 METHODS OF QUANTIFYING N2-(1-CARBOXYETHYL)-2'-DEOXY-GUANOSINE (CEdG) AND SYNTHESIS OF OLIGONUCLEOTIDES CONTAINING CEdG
03/22/2012US20120071558 Compositions of very long chain polyunsaturated fatty acids and methods of use
03/22/2012US20120071557 Animal feed compositions of abscisic acid
03/22/2012US20120071556 Pharmaceutical and nutraceutical compositions of abscisic acid
03/22/2012US20120071555 Compositions of abscisic acid for animal health
03/22/2012US20120071554 Deuterated 2-propylpentanoic acid compounds
03/22/2012US20120071552 Zinc-Monocysteine Complex and Method Of Using Zinc-Cysteine Complexes
03/22/2012US20120071550 Synergistic combinations of cartonoids and polyphenols
03/22/2012US20120071549 Anti-inflammatory composition containing macrolactin a and a derivative thereof as active ingredients
03/22/2012US20120071548 Therapeutic compositions
03/22/2012US20120071547 Compounds from soft coral, method of preparation and pharmaceutical uses thereof
03/22/2012US20120071546 Novel Glutamic Acid Decarboxylase (GAD) Chimera And Methods Of Use
03/22/2012US20120071545 Compositions and methods for treatment of bacterial and mycobacterial infections
03/22/2012US20120071544 Methods For Identifying Compounds Effective To Increase The Expression Or Activity Of Aspartyl Aminopeptidase In Mammalian Pancreatic Islet Cells, And Methods For Decreasing Angiotensin II Levels In Mammalian Pancreatic Islet Cells
03/22/2012US20120071542 Application of Highly Conserved Domain Sequences From Viral Genome As Template To Design Therapeutic Slirnas
03/22/2012US20120071541 Micro-RNA Associated With Rheumatoid Arthritis
03/22/2012US20120071540 Compositions and Methods Using siRNA Molecules and siRNA Cocktails for the Treatment of Breast Cancer
03/22/2012US20120071539 Compounds and methods for modulating the silencing of a polynucleotide of interest
03/22/2012US20120071538 Pharmaceutical formulatons
03/22/2012US20120071537 New Oral Formulation
03/22/2012US20120071536 N-[(2-azabicyclo[2.1.1]hex-1-yl)-aryl-methyl]-benzamide derivatives, preparation thereof, and therapeutic use thereof
03/22/2012US20120071535 Estrogen receptor modulators and uses thereof
03/22/2012US20120071534 Lxr modulators
03/22/2012US20120071533 Anti-fungal formulation
03/22/2012US20120071532 Novel solid forms of bendamustine hydrochloride
03/22/2012US20120071531 Use of Fungicides for the Treatment of Fish Mycoses
03/22/2012US20120071529 Tetrazole Compounds Which Selectively Modulate The CB2 Receptor
03/22/2012US20120071528 Methods and compositions for treatment of diabetes and dyslipidemia
03/22/2012US20120071527 Therapeutic compounds
03/22/2012US20120071526 Compounds for the treatment of metabolic disorders
03/22/2012US20120071524 Compounds for treatment of cancer
03/22/2012US20120071523 Benzofuran-4,5-diones as selective peptide deformylase inhibitors
03/22/2012US20120071521 Concentrated, non-foaming solution of quaternary ammonium compounds and methods of use
03/22/2012US20120071520 Crystalline phases of 2'--biphenyl-2-carboxylic acid (2-pyridin-3-yl-ethyl)-amide
03/22/2012US20120071519 CRYSTALLINE FORMS OF A FACTOR Xa INHIBITOR
03/22/2012US20120071518 Treatment of Sepsis with 5-Ethyl-1-Phenyl-2(1H)-Pyridone
03/22/2012US20120071516 Compounds that modulate intracellular calcium
03/22/2012US20120071515 Nitropyridinyl ethyleneimine compound, the pharmaceutical composition containing it, the preparation method and use thereof
03/22/2012US20120071514 Benzoxazolone derivatives as aldosterone synthase inhibitors
03/22/2012US20120071513 Compositions and Their Use as Anti-Tumor Agents
03/22/2012US20120071512 5-pyridin-3-yl-1, 3-dihydro-indol-2-on derivatives and their use as modulators of aldosterone synthase and/or cyp11b1
03/22/2012US20120071511 Fentanyl-containing adhesive preparation for external use
03/22/2012US20120071510 Method and Composition for Treating Migraines
03/22/2012US20120071509 process
03/22/2012US20120071508 Cyclic-alkylamine derivatives as inhibitors of the interaction between mdm2 and p53
03/22/2012US20120071507 Treatment regimen utilizing neratinib for breast cancer
03/22/2012US20120071506 Methods for treating cns disorders with bicyclo-substituted 2-imidazoline and 2-imidazoles
03/22/2012US20120071505 Substituted pyridine derivatives, pharmaceutical compositions, and methods of use to treat oxidative stress
03/22/2012US20120071504 Modulators of cystic fibrosis transmembrane conductance regulator
03/22/2012US20120071503 Positive allosteric modulators of group ii mglurs
03/22/2012US20120071502 Novel phenoxyisobutyric acid compounds and methods for synthesis
1 ... 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 ... 7860